Alexandre Prehn Zavascki

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019 · 931 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

Ana Maria Sandri, Cornelia B. Landersdorfer, Jovan Jacob et al. · Clinical Infectious Diseases · 2013 · 428 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients

Alexandre Prehn Zavascki, Luciano Zubaran Goldani, Guoying Cao et al. · Clinical Infectious Diseases · 2008 · 234 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium

Felipe Francisco Tuon, Maria Helena Rigatto, Cesar K. Lopes et al. · International Journal of Antimicrobial Agents · 2013 · 146 citations

Medicine, Nephrology, Renal Pathophysiology +11

Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B

Maria Helena Rigatto, Maura Salaroli de Oliveira, Lauro Vieira Perdigão Neto et al. · Antimicrobial Agents and Chemotherapy · 2016 · 139 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14